M. Laughlin

发表

Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.

O. Bagasra, R. Pomerantz, L. Duan, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Effect of food on the relative bioavailability of two oral formulations of posaconazole in healthy adults.

E. Radwanski, R. Courtney, Josephine Lim, 2003, British journal of clinical pharmacology.

Ribavirin dosing in chronic hepatitis C: Application of population pharmacokinetic‐pharmacodynamic models

G. Hajian, Samir K. Gupta, P. Glue, 2002, Clinical pharmacology and therapeutics.

Chiral high-performance liquid chromatographic analysis of antifungal SCH 56592 and evaluation of its chiral inversion in animals and humans.

A. Nomeir, L. Heimark, C. Lin, 2000, Chirality.

CD4-independent infection of human neural cells by human immunodeficiency virus type 1

J. Hoxie, C. Kunsch, B. Wigdahl, 1989, Journal of Virology.

CD 4-Independent Infection of Human Neural Cells by Human Immunodeficiency Virus Type 1

J. Hoxie, C. Kunsch, B. Wigdahl, 2022 .

Role of 11β-hydroxysteroid dehydrogenase 2 renal activity in potassium homeostasis in rats with chronic renal failure

M. E. Altuna, M. C. Damasco, N. Yeyati, 2010 .

HIV Infection of Neural Cells

J. Trojanowski, J. Hoxie, J. Trojanowski, 1989 .

Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.

R. Pomerantz, L. Duan, J. W. Oakes, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Entry of Human Immunodeficiency Virus‐1 Into Glial Cells Proceeds via an Alternate, Efficient Pathway

H. Friedman, F. González-Scarano, J. Harouse, 1991, Journal of leukocyte biology.

Oral Bioavailability of Posaconazole in Fasted Healthy Subjects

R. Courtney, F. Ezzet, G. Krishna, 2005, Clinical pharmacokinetics.

Effect of posaconazole on cytochrome P450 enzymes: a randomized, open-label, two-way crossover study.

C. Banfield, R. Courtney, Josephine Lim, 2004, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Pharmacokinetics, Safety, and Tolerability of Oral Posaconazole Administered in Single and Multiple Doses in Healthy Adults

R. Courtney, V. Batra, S. Pai, 2003, Antimicrobial Agents and Chemotherapy.

Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide.

D. Silberberg, S. Spitalnik, F. González-Scarano, 1991, Science.

Posaconazole Pharmacokinetics, Safety, and Tolerability in Subjects With Varying Degrees of Chronic Renal Disease

S. Swan, W. Smith, T. Marbury, 2005, Journal of clinical pharmacology.

Use of high-performance liquid chromatographic and microbiological analyses for evaluating the presence or absence of active metabolites of the antifungal posaconazole in human plasma.

A. Nomeir, Josephine Lim, S. Indelicato, 2003, Journal of chromatography. A.

Treating fungal infections.

R. Courtney, M. Laughlin, 1980, British medical journal.

Pharmacokinetics of Posaconazole Coadministered with Antacid in Fasting or Nonfasting Healthy Men

E. Radwanski, R. Courtney, Josephine Lim, 2004, Antimicrobial Agents and Chemotherapy.

Use of amphotericin B during pregnancy: case report and review.

A. Ranzini, J. Wolf, M. Laughlin, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Assessment of The Pharmacokinetic (PK), Pharmacodynamic (PD) Interaction Potential Between Posaconazole and Glipizide in Healthy Volunteers

R. Courtney, P. Statkevich, M. Martinho, 2003 .

Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.

R. Pomerantz, G. Dornadula, H. Zhang, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation.

C. Debouck, D. Kolson, J. W. Balliet, 1994, The Journal of general virology.

Sodium butyrate stimulation of HIV-1 gene expression: a novel mechanism of induction independent of NF-kappa B.

R. Pomerantz, F. González-Scarano, G. Chang, 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial

S. Hendrix, G. Wilcock, K. Zavitz, 2008, The Lancet Neurology.

Sodium butyrate treatment of cells latently infected with HIV-1 results in the expression of unspliced viral RNA.

D. Kolson, R. Pomerantz, J. Alwine, 1993, Virology.

Human choroid plexus cells can be latently infected with human immunodeficiency virus

W. Hickey, Z. Wróblewska, F. González-Scarano, 1989, Annals of neurology.

Human immunodeficiency virus type 1 Tat activity in human neuronal cells: uptake and trans-activation.

Laughlin, C. Debouck, D. Kolson, 1994, The Journal of general virology.